DexCom Announces Leadership Transition As Jake Leach Assumes Expanded Role As President and CEO

Benzinga · 5d ago
  • Mr. Leach begins his inaugural year as CEO with speaking engagements at CES 2026 and the 44th annual J.P. Morgan Healthcare Conference
  • A completely reimagined Stelo app experience will launch this year, further advancing personalized health technology for consumers interested in metabolic health
  • With continued investments across its portfolio, including the pharmacy launch of Dexcom G7 15 Day and AI-driven enhanced features, Dexcom is poised to transform even more lives through its glucose biosensing technology in 2026

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, is ushering in the next era of transformative, customer-driven innovation under the leadership of President and CEO Jake Leach, who assumed his expanded responsibilities on Jan. 1.